{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:13:25Z","timestamp":1793330005575,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["ZIA AA000301"],"award-info":[{"award-number":["ZIA AA000301"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["ZIA AA000421"],"award-info":[{"award-number":["ZIA AA000421"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Only ~20% of heavy drinkers develop alcohol cirrhosis (AC). While differences in metabolism, inflammation, signaling, microbiome signatures and genetic variations have been tied to the pathogenesis of AC, the key underlying mechanisms for this interindividual variability, remain to be fully elucidated. Induced pluripotent stem cell-derived hepatocytes (iHLCs) from patients with AC and healthy controls differ transcriptomically, bioenergetically and histologically. They include a greater number of lipid droplets (LDs) and LD-associated mitochondria compared to control cells. These pre-pathologic indicators are effectively reversed by Aramchol, an inhibitor of stearoyl-CoA desaturase. Bioenergetically, AC iHLCs have lower spare capacity, slower ATP production and their mitochondrial fuel flexibility towards fatty acids and glutamate is weakened. MARC1 and PNPLA3, genes implicated by GWAS in alcohol cirrhosis, show to correlate with lipid droplet-associated and mitochondria-mediated oxidative damage in AC iHLCs. Knockdown of PNPLA3 expression exacerbates mitochondrial deficits and leads to lipid droplets alterations. These findings suggest that differences in mitochondrial bioenergetics and lipid droplet formation are intrinsic to AC hepatocytes and can play a role in its pathogenesis.<\/jats:p>","DOI":"10.1038\/s41467-024-47085-y","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T12:53:06Z","timestamp":1714567986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A patient-based iPSC-derived hepatocyte model of alcohol-associated cirrhosis reveals bioenergetic insights into disease pathogenesis"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9854-9418","authenticated-orcid":false,"given":"Bani","family":"Mukhopadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Marietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Oiseni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faridoddin","family":"Mirshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mazzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Hodgkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5880-8702","authenticated-orcid":false,"given":"Qiaoping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1178-917X","authenticated-orcid":false,"given":"Daniel","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kunos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8682-5748","authenticated-orcid":false,"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1724-5405","authenticated-orcid":false,"given":"David","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,1]]},"reference":[{"key":"47085_CR1","unstructured":"NIAAA. Alcohol Use Disorder (AUD) in the United States: Age Groups and Demographic Characteristics. (2023)."},{"key":"47085_CR2","unstructured":"CDC. Chronic Liver Disease and Cirrhosis, (2023)."},{"key":"47085_CR3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1194\/jlr.M066175","volume":"57","author":"P Puri","year":"2016","unstructured":"Puri, P. et al. Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese. J. Lipid Res. 57, 1017\u20131028 (2016).","journal-title":"J. Lipid Res."},{"key":"47085_CR4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","volume":"5","author":"S Mitra","year":"2020","unstructured":"Mitra, S., De, A. & Chowdhury, A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Transl. Gastroenterol. Hepatol. 5, 16 (2020).","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"47085_CR5","unstructured":"HRSA. OPTN\/SRTR 2019 Annual Data Report: Liver) (2019)."},{"key":"47085_CR6","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.3748\/wjg.v24.i45.5063","volume":"24","author":"A Lamas-Paz","year":"2018","unstructured":"Lamas-Paz, A. et al. Alcoholic liver disease: Utility of animal models. World J. Gastroenterol. 24, 5063\u20135075 (2018).","journal-title":"World J. Gastroenterol."},{"key":"47085_CR7","first-page":"III","volume":"161","author":"Z Kmiec","year":"2001","unstructured":"Kmiec, Z. Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell Biol. 161, III\u2013XIII (2001).","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"47085_CR8","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/gutjnl-2016-313379","volume":"66","author":"EM Brunt","year":"2017","unstructured":"Brunt, E. M. & Kleiner, D. E. Challenges in the hepatic histopathology in non-alcoholic fatty liver disease. Gut 66, 1539\u20131540 (2017).","journal-title":"Gut"},{"key":"47085_CR9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/cld.172","volume":"2","author":"ND Theise","year":"2013","unstructured":"Theise, N. D. Histopathology of alcoholic liver disease. Clin. Liver Dis. 2, 64\u201367 (2013).","journal-title":"Clin. Liver Dis."},{"key":"47085_CR10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature12271","volume":"499","author":"T Takebe","year":"2013","unstructured":"Takebe, T. et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499, 481\u2013484 (2013).","journal-title":"Nature"},{"key":"47085_CR11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00595-020-02092-6","volume":"51","author":"Y Saito","year":"2021","unstructured":"Saito, Y., Ikemoto, T., Morine, Y. & Shimada, M. Current status of hepatocyte-like cell therapy from stem cells. Surg. Today 51, 340\u2013349 (2021).","journal-title":"Surg. Today"},{"key":"47085_CR12","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.31535","volume":"73","author":"TH Schwantes-An","year":"2021","unstructured":"Schwantes-An, T. H. et al. Genome-wide association study and meta-analysis on alcohol-associated liver cirrhosis identifies genetic risk factors. Hepatology 73, 1920\u20131931 (2021).","journal-title":"Hepatology"},{"key":"47085_CR13","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1053\/j.gastro.2020.06.014","volume":"159","author":"H Innes","year":"2020","unstructured":"Innes, H. et al. Genome-wide association study for alcohol-related cirrhosis identifies risk loci in MARC1 and HNRNPUL1. Gastroenterology 159, 1276\u20131289.e1277 (2020).","journal-title":"Gastroenterology"},{"key":"47085_CR14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/CS20140101","volume":"127","author":"BK Chacko","year":"2014","unstructured":"Chacko, B. K. et al. The Bioenergetic Health Index: a new concept in mitochondrial translational research. Clin. Sci. 127, 367\u2013373 (2014).","journal-title":"Clin. Sci."},{"key":"47085_CR15","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/s41591-021-01495-3","volume":"27","author":"V Ratziu","year":"2021","unstructured":"Ratziu, V. et al. Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial. Nat. Med. 27, 1825\u20131835 (2021).","journal-title":"Nat. Med."},{"key":"47085_CR16","doi-asserted-by":"crossref","first-page":"42795","DOI":"10.1074\/jbc.M112.419424","volume":"287","author":"JM Klein","year":"2012","unstructured":"Klein, J. M. et al. The mitochondrial amidoxime-reducing component (mARC1) is a novel signal-anchored protein of the outer mitochondrial membrane. J. Biol. Chem. 287, 42795\u201342803 (2012).","journal-title":"J. Biol. Chem."},{"key":"47085_CR17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/cld.124","volume":"2","author":"L Sibulesky","year":"2013","unstructured":"Sibulesky, L. Normal liver anatomy. Clin. Liver Dis. 2, S1\u2013S3 (2013).","journal-title":"Clin. Liver Dis."},{"key":"47085_CR18","doi-asserted-by":"crossref","first-page":"19002","DOI":"10.1074\/jbc.M109.068460","volume":"285","author":"B Mukhopadhyay","year":"2010","unstructured":"Mukhopadhyay, B. et al. Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma. J. Biol. Chem. 285, 19002\u201319011 (2010).","journal-title":"J. Biol. Chem."},{"key":"47085_CR19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1194\/jlr.R119000547","volume":"61","author":"S Jeon","year":"2020","unstructured":"Jeon, S. & Carr, R. Alcohol effects on hepatic lipid metabolism. J. Lipid Res. 61, 470\u2013479 (2020).","journal-title":"J. Lipid Res."},{"key":"47085_CR20","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/j.gastro.2008.01.016","volume":"134","author":"N Horiguchi","year":"2008","unstructured":"Horiguchi, N. et al. Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 134, 1148\u20131158 (2008).","journal-title":"Gastroenterology"},{"key":"47085_CR21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jhep.2020.10.035","volume":"74","author":"S Stein","year":"2021","unstructured":"Stein, S. et al. IL-17A\/F enable cholangiocytes to restrict T-cell-driven experimental cholangitis by upregulating PD-L1 expression. J. Hepatol. 74, 919\u2013930 (2021).","journal-title":"J. Hepatol."},{"key":"47085_CR22","volume":"3","author":"D Bhattacharya","year":"2021","unstructured":"Bhattacharya, D. et al. Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis. JHEP Rep. 3, 100237 (2021).","journal-title":"JHEP Rep."},{"key":"47085_CR23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cmet.2019.02.011","volume":"29","author":"IY Benador","year":"2019","unstructured":"Benador, I. Y., Veliova, M., Liesa, M. & Shirihai, O. S. Mitochondria bound to lipid droplets: where mitochondrial dynamics regulate lipid storage and utilization. Cell Metab. 29, 827\u2013835 (2019).","journal-title":"Cell Metab."},{"key":"47085_CR24","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3390\/cells10092273","volume":"10","author":"X Ma","year":"2021","unstructured":"Ma, X., Qian, H., Chen, A., Ni, H. M. & Ding, W. X. Perspectives on mitochondria-ER and mitochondria-lipid droplet contact in hepatocytes and hepatic lipid metabolism. Cells 10, 2273 (2021).","journal-title":"Cells"},{"key":"47085_CR25","doi-asserted-by":"crossref","first-page":"16724","DOI":"10.1074\/jbc.RA118.004049","volume":"293","author":"PA Young","year":"2018","unstructured":"Young, P. A. et al. Long-chain acyl-CoA synthetase 1 interacts with key proteins that activate and direct fatty acids into niche hepatic pathways. J. Biol. Chem. 293, 16724\u201316740 (2018).","journal-title":"J. Biol. Chem."},{"key":"47085_CR26","first-page":"6","volume":"35","author":"S Zakhari","year":"2013","unstructured":"Zakhari, S. Alcohol metabolism and epigenetics changes. Alcohol Res. 35, 6\u201316 (2013).","journal-title":"Alcohol Res."},{"key":"47085_CR27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12929-019-0527-8","volume":"26","author":"K Okabe","year":"2019","unstructured":"Okabe, K., Yaku, K., Tobe, K. & Nakagawa, T. Implications of altered NAD metabolism in metabolic disorders. J. Biomed. Sci. 26, 34 (2019).","journal-title":"J. Biomed. Sci."},{"key":"47085_CR28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cmet.2014.06.001","volume":"20","author":"T Nakagawa","year":"2014","unstructured":"Nakagawa, T. & Guarente, L. SnapShot: sirtuins, NAD, and aging. Cell Metab. 20, 192\u2013192.e191 (2014).","journal-title":"Cell Metab."},{"key":"47085_CR29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20110162","volume":"435","author":"MD Brand","year":"2011","unstructured":"Brand, M. D. & Nicholls, D. G. Assessing mitochondrial dysfunction in cells. Biochem J. 435, 297\u2013312 (2011).","journal-title":"Biochem J."},{"key":"47085_CR30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","volume":"36","author":"GJ van der Windt","year":"2012","unstructured":"van der Windt, G. J. et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36, 68\u201378 (2012).","journal-title":"Immunity"},{"key":"47085_CR31","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.18632\/aging.102058","volume":"11","author":"RK Kurupati","year":"2019","unstructured":"Kurupati, R. K., Haut, L. H., Schmader, K. E. & Ertl, H. C. Age-related changes in B cell metabolism. Aging (Albany NY) 11, 4367\u20134381 (2019).","journal-title":"Aging (Albany NY)"},{"key":"47085_CR32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.tem.2017.06.004","volume":"28","author":"L Valcarcel-Jimenez","year":"2017","unstructured":"Valcarcel-Jimenez, L., Gaude, E., Torrano, V., Frezza, C. & Carracedo, A. Mitochondrial metabolism: yin and yang for tumor progression. Trends Endocrinol. Metab. 28, 748\u2013757 (2017).","journal-title":"Trends Endocrinol. Metab."},{"key":"47085_CR33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cbi.2010.12.002","volume":"191","author":"BE Sansbury","year":"2011","unstructured":"Sansbury, B. E., Jones, S. P., Riggs, D. W., Darley-Usmar, V. M. & Hill, B. G. Bioenergetic function in cardiovascular cells: the importance of the reserve capacity and its biological regulation. Chem. Biol. Interact. 191, 288\u2013295 (2011).","journal-title":"Chem. Biol. Interact."},{"key":"47085_CR34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3945\/an.113.004648","volume":"4","author":"DG Mashek","year":"2013","unstructured":"Mashek, D. G. Hepatic fatty acid trafficking: multiple forks in the road. Adv. Nutr. 4, 697\u2013710 (2013).","journal-title":"Adv. Nutr."},{"key":"47085_CR35","doi-asserted-by":"crossref","first-page":"e135626","DOI":"10.1172\/jci.insight.135626","volume":"6","author":"ES Selen","year":"2021","unstructured":"Selen, E. S., Choi, J. & Wolfgang, M. J. Discordant hepatic fatty acid oxidation and triglyceride hydrolysis leads to liver disease. JCI Insight 6, e135626 (2021).","journal-title":"JCI Insight"},{"key":"47085_CR36","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461\u20131465 (2008).","journal-title":"Nat. Genet."},{"key":"47085_CR37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng.488","volume":"42","author":"C Tian","year":"2010","unstructured":"Tian, C., Stokowski, R. P., Kershenobich, D., Ballinger, D. G. & Hinds, D. A. Variant in PNPLA3 is associated with alcoholic liver disease. Nat. Genet. 42, 21\u201323 (2010).","journal-title":"Nat. Genet."},{"key":"47085_CR38","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1172\/JCI65179","volume":"122","author":"JZ Li","year":"2012","unstructured":"Li, J. Z. et al. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J. Clin. Investig. 122, 4130\u20134144 (2012).","journal-title":"J. Clin. Investig."},{"key":"47085_CR39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1194\/jlr.M011205","volume":"52","author":"MK Basantani","year":"2011","unstructured":"Basantani, M. K. et al. Pnpla3\/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J. Lipid Res. 52, 318\u2013329 (2011).","journal-title":"J. Lipid Res."},{"key":"47085_CR40","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jhep.2020.04.021","volume":"73","author":"PK Luukkonen","year":"2020","unstructured":"Luukkonen, P. K. et al. MARC1 variant rs2642438 increases hepatic phosphatidylcholines and decreases severity of non-alcoholic fatty liver disease in humans. J. Hepatol. 73, 725\u2013726 (2020).","journal-title":"J. Hepatol."},{"key":"47085_CR41","doi-asserted-by":"crossref","first-page":"10345","DOI":"10.1074\/jbc.M114.555177","volume":"289","author":"CE Sparacino-Watkins","year":"2014","unstructured":"Sparacino-Watkins, C. E. et al. Nitrite reductase and nitric-oxide synthase activity of the mitochondrial molybdopterin enzymes mARC1 and mARC2. J. Biol. Chem. 289, 10345\u201310358 (2014).","journal-title":"J. Biol. Chem."},{"key":"47085_CR42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","volume":"61","author":"E Smagris","year":"2015","unstructured":"Smagris, E. et al. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Hepatology 61, 108\u2013118 (2015).","journal-title":"Hepatology"},{"key":"47085_CR43","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3109\/10715762.2013.819428","volume":"47","author":"B Sid","year":"2013","unstructured":"Sid, B., Verrax, J. & Calderon, P. B. Role of oxidative stress in the pathogenesis of alcohol-induced liver disease. Free Radic. Res. 47, 894\u2013904 (2013).","journal-title":"Free Radic. Res."},{"key":"47085_CR44","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.3390\/jcm10143011","volume":"10","author":"A Michalak","year":"2021","unstructured":"Michalak, A., Lach, T. & Cichoz-Lach, H. Oxidative stress-a key player in the course of alcohol-related liver disease. J. Clin. Med. 10, 3011 (2021).","journal-title":"J. Clin. Med."},{"key":"47085_CR45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4254\/wjh.v12.i7.332","volume":"12","author":"HK Tan","year":"2020","unstructured":"Tan, H. K., Yates, E., Lilly, K. & Dhanda, A. D. Oxidative stress in alcohol-related liver disease. World J. Hepatol. 12, 332\u2013349 (2020).","journal-title":"World J. Hepatol."},{"key":"47085_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3164\/jcbn.14-42","volume":"56","author":"HP Indo","year":"2015","unstructured":"Indo, H. P. et al. A mitochondrial superoxide theory for oxidative stress diseases and aging. J. Clin. Biochem Nutr. 56, 1\u20137 (2015).","journal-title":"J. Clin. Biochem Nutr."},{"key":"47085_CR47","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3390\/antiox9100909","volume":"9","author":"M Mari","year":"2020","unstructured":"Mari, M. et al. Mitochondrial glutathione: recent insights and role in disease. Antioxidants 9, 909 (2020).","journal-title":"Antioxidants"},{"key":"47085_CR48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/jcm6070071","volume":"6","author":"KM Stepien","year":"2017","unstructured":"Stepien, K. M. et al. Evidence of oxidative stress and secondary mitochondrial dysfunction in metabolic and non-metabolic disorders. J. Clin. Med. 6, 71 (2017).","journal-title":"J. Clin. Med."},{"key":"47085_CR49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1134\/S0026893318020097","volume":"52","author":"A Panov","year":"2018","unstructured":"Panov, A. Perhydroxyl radical (HO2^(*)) as inducer of the isoprostane lipid peroxidation in mitochondria. Mol. Biol. 52, 347\u2013359 (2018).","journal-title":"Mol. Biol."},{"key":"47085_CR50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.chemphyslip.2019.03.011","volume":"221","author":"A Gegotek","year":"2019","unstructured":"Gegotek, A. & Skrzydlewska, E. Biological effect of protein modifications by lipid peroxidation products. Chem. Phys. Lipids 221, 46\u201352 (2019).","journal-title":"Chem. Phys. Lipids"},{"key":"47085_CR51","unstructured":"Jennifer C. Moore R. P. H., Michael H. Sheldon. Biobanking in the Era of the Stem Cell: A Technical and Operational Guide. Morgan & Claypool Publishers (2012)."},{"key":"47085_CR52","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nprot.2014.020","volume":"9","author":"T Takebe","year":"2014","unstructured":"Takebe, T. et al. Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nat. Protoc. 9, 396\u2013409 (2014).","journal-title":"Nat. Protoc."},{"key":"47085_CR53","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1093\/nar\/gkt111","volume":"41","author":"L Varemo","year":"2013","unstructured":"Varemo, L., Nielsen, J. & Nookaew, I. Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods. Nucleic Acids Res. 41, 4378\u20134391 (2013).","journal-title":"Nucleic Acids Res."},{"key":"47085_CR54","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1172\/JCI42551","volume":"120","author":"J Tam","year":"2010","unstructured":"Tam, J. et al. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. J. Clin. Investig. 120, 2953\u20132966 (2010).","journal-title":"J. Clin. Investig."},{"key":"47085_CR55","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10534-0","volume":"10","author":"AK Glaser","year":"2019","unstructured":"Glaser, A. K. et al. Multi-immersion open-top light-sheet microscope for high-throughput imaging of cleared tissues. Nat. Commun. 10, 2781 (2019).","journal-title":"Nat. Commun."},{"key":"47085_CR56","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.7717\/peerj.349","volume":"2","author":"N Nishimura","year":"2014","unstructured":"Nishimura, N., Gotoh, T., Oike, Y. & Yano, M. TMEM65 is a mitochondrial inner-membrane protein. PeerJ 2, e349 (2014).","journal-title":"PeerJ"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47085-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47085-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47085-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:11:31Z","timestamp":1738260691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47085-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["47085"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-47085-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,1]]},"assertion":[{"value":"28 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors do not have any financial and non-financial interest in design or preparation of the manuscript. D.M. receives a salary from Leica Microsystems where he is Manager for Aivia Software, however received no compensation to assist for this manuscript. A.J.S. have stock options in Genfit, Akarna, Tiziana, Durect Inversago, and Galmed. He has served as a consultant to Astra Zeneca, Salix, Tobira, Takeda, Jannsen, Gilead, Terns, Birdrock, Merck, Valeant, Boehringer Ingelheim, Bristol Myers Squibb, Lilly, Hemoshear, Novartis, Novo Nordisk, Pfizer, 89 bio, Regeneron, Alnylam, Akero, Tern, Histoindex, Corcept, Poxel, Path AI, and Genfit. His institution has received grant support from Gilead, Salix, Tobira, Bristol Myers, Shire, Intercept, Merck, Astra Zeneca, Malinckrodt and Novartis. He receives royalties from Elsevier and UptoDate. However, A.J.S. received no compensation from any source for this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2869"}}